Chromosomal translocations involving BCL6 gene are frequent in human B-cell lymphomas. Chromosomal breaks preferentially occur within a 3-kb region containing the ®rst exon and intron. Recent reports have revealed that internal deletions or point mutations also are common in this region, suggesting that structural alteration of this region may be a crucial event in the development of lymphomas. In this study, we identi®ed two regions in the BCL6 gene that negatively regulate BCL6 expression. One region, ES, is located within the ®rst exon between nucleotides +472 and +543, and a second region, IS, is located between +783 and +918 of the ®rst intron. A consensus nucleotide sequence for the binding of the BCL6 protein itself was found within the ES region. An electrophoretic mobility shift assay and a co-transfection experiment using a BCL6 expression vector showed that transcription of the BCL6 gene was negatively regulated by the BCL6 gene product. The IS region which is included in the regions commonly deleted in B-cell lymphomas had a silencer activity. Structural alterations of these two regions may play roles in the deregulated expression of the BCL6 gene in B-cell lymphomas. Oncogene (2000) 19, 4941 ± 4945.
A chromosomal translocation involving 3q27 is one of the most common cytogenetic abnormalities in human B-cell lymphomas. The BCL6 gene, encoding a zinc®nger transcriptional repressor, has been isolated from the breakpoint at 3q27 (Baron et al., 1993; Kerckaert et al., 1993; Miki et al., 1994; Ye et al., 1993) . The translocation preferentially occurs within a 3-kb region spanning the ®rst exon-intron boundary. The promoter region and ®rst non-coding exon are replaced by other genes including the immunoglobulin (Ig) genes, and the resulting deregulated expression of BCL6 may contribute to lymphomagenesis.
Recent studies have found that some lymphomas carry internal deletions (Bernardin et al., 1997; Nakamura et al., 1996; 1999) , and more frequently, point mutations Gaidano et al., 1997; Liang et al., 1998; Migliazza et al., 1995) within the BCL6 gene. Interestingly, the deletions and mutations preferentially occur within the ®rst exonintron boundary region, the same region in which the breakpoints for chromosomal translocation cluster. These observations suggest that the structural alteration of this region, which may contain regulatory sequences, is a crucial event in the development of Bcell lymphomas.
To investigate the functional signi®cance of the ®rst exon-intron boundary region on the transcriptional regulation of the BCL6 gene, luciferase reporter constructs carrying various genomic fragments of this region were transfected transiently into Raji cells, expressing endogenous BCL6 ( Figure  1A ). pBCL7657/471Luc, containing the region from 7657 to +471, showed signi®cant luciferase activity in Raji cells, as previously reported (Ohashi et al., 1995) . We arbitrarily de®ned the luciferase activity of pBCL7657/471Luc as 100% and used this as a reference to normalize the luciferase activity data of the other constructs. The luciferase activity of pBCL7657/543Luc was reduced to 68%, suggesting that this 72-bp region from +472 to +543 (corresponding to the last 72 bp of the ®rst exon, designated as ES) contains a negative regulatory element. When the 3'-end of the fragment was extended to the ®rst intron of the nucleotide position at +918, the luciferase activity was reduced markedly to 5%, suggesting that another negative regulatory element is present within the region between +783 to +918 (designated as IS). These results also were supported by the observation that speci®c deletions of the ES (pBCL7657/1261D472/542Luc) and IS (pBCL7657/ 1261D784/917Luc) regions result in modest, but signi®cant, increases in luciferase activities when compared to that of the wild type pBCL7657/ 1261Luc. Another deletion construct of pBCL7657/ 1261D472/542D784/917Luc, which lacks both the ES and IS sequences, also yielded a higher luciferase activity in an additive way.
Next, these regions were inserted downstream of the luciferase gene of the construct pBCL7657/471Luc in the sense (pBCL7657/471LucES-s and pBCL7657/ 471LucIS-s) or antisense (pBCL7657/471LucES-as and pBCL7657/471LucIS-as) orientations with respect to the BCL6 promoter ( Figure 1B) . The luciferase activities of pBCL7657/471LucIS-s, pBCL7657/ 471LucIS-as and pBCL7657/471LucES-s were signi®-cantly lower than that of pBCL7657/471Luc. The luciferase activity of pBCL7657/471LucES-as, how-ever, was comparable to that of pBCL7657/471Luc. These results indicate that the IS has a silencer activity, and that the ES region acts as a negative element.
The ES or IS region also was inserted into the reporter plasmids pIgkLuc and pH2Bluc, which contain the B-cell speci®c promoter of the Igk light chain gene and the ubiquitously active promoter of the H2B histone gene, respectively ( Figure 2C ). The luciferase assay revealed that the ES and IS regions eectively repress expression from both the Igk and H2B promoters, indicating that the ES and IS regions act as repressive elements against heterologous promoters.
We next performed electrophoretic mobility shift assay (EMSA) to determine whether Raji cells contain nuclear proteins which speci®cally bind to the ES or IS sequences (Figure 2A , B). DNA-protein complexes were observed and these bindings were speci®cally competed by a 10-fold molar excess of unlabeled speci®c probes, but not by the presence of a 100-fold molar excess of unrelated competitor DNA fragments.
These results suggest that Raji cells contain nuclear proteins which speci®cally bind to the ES or IS sequence.
In the ES region, there is a 14-bp sequence of AAGTTTCTAGGAAA (+520 to +533), which is similar to the consensus binding site of the BCL6 protein, (T/A)NCTTTCNAGG(A/G)AT , and matches it in 12/14 nucleotides. Subsequent EMSA showed that the bacterially expressed GST-BCL6 fusion protein can bind to the ES probe ( Figure 2C ). A mutated ES probe which contains a 2-bp mismatch could not bind the BCL6 fusion protein. The mutated probe also failed to form a complex with nuclear extracts from Raji cells ( Figure  2C ). Furthermore, a supershift experiment using the ES probe and nuclear extracts from Raji cells showed that the shifted band was markedly attenuated by the addition of anti-BCL6 antibody ( Figure 2D ). These results indicate that the BCL6 protein speci®cally binds to the ES region. and ®rst intron (solid line) of the human BCL6 gene was cloned from placenta cosmid library (Ohashi et al., 1995) . Various deletion mutants subcloned into a pGL3-Basic vector were created by digesting with appropriate restriction endonucleases, or by using exonuclease III and S1 nuclease (Erase-a Base System, Promega), or by polymerase chain reactions. Ten mg of each construct together with 1 mg of the control plasmid pRL-TK was transiently transfected into Raji cells by electroporation. Luciferase activities were assayed using a Dual-luciferase reporter assay system (Promega), and are expressed in percentages relative to that of pBCL7657/471Luc. The identi®ed regions (ES and IS) are also indicated. The averages of luciferase activities were determined by three or more independent experiments performed in a duplicate and expressed with 1 s.d. as bars. (B) Negative regulatory elements in the ®rst exon (ES region from +472 to +543) or in the ®rst intron (IS region from +783 to +918) of the BCL6 gene were inserted into the downstream to the luciferase gene (Luc) of pBCL7657/471Luc in both sense (pBCL7657/471LucES-s and pBCL7657/471LucIS-s) and antisense (pBCL7657/471LucES-as and pBCL7657/471LucIS-as) orientations. Luciferase activities relative to that of pBCL7657/471Luc are shown in percentages. (C) The ES and IS regions were also inserted into pIgkLuc or pH2BLuc vector, which contains the promoters of Igk light chain (Igk) and H2B histone (H2B) genes, respectively. Each construct was transfected into Raji cells. Luciferase activities are expressed in percentages relative to that of pBCL7657/471Luc, pIgkLuc or pH2BLuc
Negative regulation of the BCL6 gene M Kikuchi et al Figure 2 Electrophoretic mobility shift assay using nuclear extracts from Raji cells or GST-BCL6 fusion protein. A doublestranded DNA fragments containing the ES (A) or IS (B) region were 32 P-labeled by Klenow enzyme. Three ng of probes were incubated with nuclear extracts from Raji cells and 2 mg of poly (dI-dC) in a binding buer (10 mM HEPES (pH 7.8), 50 mM KCl, 1 mM EDTA, 5 mM MgCl 2 , and 10% glycerol) for 20 min at room temperature and then separated through a nondenaturing polyacrylamide gel at 48C. The speci®cities of the complexes were evaluated by competitions with 10-fold (610) and 100-fold (6100) excess of the unlabeled double-stranded probe of each fragment (speci®c) or of two dierent, unrelated DNA fragments (unrelated 1, a 198-bp fragment derived from neomycin resistance gene or unrelated 2, a 150-bp fragment derived from LacZ gene). Shifted bands are indicated by arrows. (C) A double-stranded DNA fragments of wild-type ES (WT) or mutated ES (Mut, nucleotides at +524 from T to G and at +525 from T to C) were labeled by 32 P and used as a probe. Probes were incubated with bacterially expressed GST-BCL6 fusion protein or nuclear extracts from Raji. (D) A double-stranded, radioactive ES fragment was incubated with nuclear extracts from Raji in the presence of rabbit polyclonal antibody against human BCL6 (aBCL6) or unrelated antibody (NRS). Shifted bands are indicated by an arrow To determine whether the binding of the BCL6 protein to the ES region is functional, we transiently transfected pTKLucES containing the thymidine kinase gene promoter and ES sequence, together with the BCL6 expressing plasmid pEFLacBCL6, into 293 or 10T1/2 cells (Figure 3 ). These cell lines do not normally express BCL6. The luciferase activities of pTKLucES were comparable to those of the parental plasmid pTKLuc when co-transfected with the empty vector pEFLac. However, the co-transfection of pTKLucES and pEFLacBCL6 resulted in a signi®cant reduction in the level of luciferase expression. The results were consistent with those of previous studies, indicating that BCL6 acts as a sequence-speci®c transcriptional repressor (Albagli et al., 1996; Chang et al., 1996; Deweindt et al., 1995; Seyfert et al., 1996) . From these results, we conclude that the BCL6 protein binds to the ES sequence and actually represses BCL6 gene transcription.
In this study, we have identi®ed two cis-acting regions, designated as ES and IS, within the ®rst exon and ®rst intron of the BCL6 gene, respectively, which negatively regulate BCL6 expression. We found that the nucleotide sequences of the ES and IS regions in the BCL6 gene (Bernardin et al., 1997) are highly conserved between humans and mice (100% homology in ES and 65.9% in IS). In addition, the deletions within the BCL6 gene in the ®ve cases of lymphomas previously reported were also found to occur in the ®rst exon-intron boundary region spanning ES and IS (Bernardin et al., 1997; Chen et al., 1998; Nakamura et al., 1996; 1999) . These observations strongly suggest that the ES and IS regions have important roles in the transcriptional regulation of the BCL6 gene, and their alteration may be a crucial event in lymphomagenesis. Cattoretti et al. (1997) have reported that the stimulation of CD40 by CD40L resulted in a signi®cant decrease of BCL6 mRNA within several hours in GC-derived B-cell lines that did not have any BCL6 gene rearrangements, while no downregulation of BCL6 mRNA was observed in cell lines harboring BCL6 gene rearrangements, in which BCL6 expression is controlled by CD40-unresponsive promoters. Because the interaction between CD40 and CD40L plays important roles in B cells, including activation, dierentiation into antibody-producing cells in T-cellmediated immune responses and survival from apoptotic stimuli (Klaus et al., 1997) , the lack of physiologic downregulation of BCL6 by CD40 in lymphoma cells may interfere with the normal development of B cells. But we could not con®rm that the CD40-stimulationinduced repression of BCL6 is mediated by the IS region using EMSA (data not shown).
More recently, somatic hypermutations of the BCL6 gene have been found not only in lymphoma cells, but also in normal GC B cells (Pasqualucci et al., 1998; Shen et al., 1998) . This is similar to the hypermutation of the Igs variable heavy chain gene, which physiologically occurs in GC B cells to produce high-anity antibodies against antigens. Mutations were detected within a 790-bp fragment located approximately 100-bp downstream of the ®rst exon. Although the IS region is entirely included within this 790-bp fragment, the region did not cover all mutation sites. Thus, it seems unlikely that all mutations of the BCL6 gene which were found in lymphoma cells are involved in oncogenesis.
The expression of BCL6 was negatively controlled by autoregulation mediated by the ES region present in the ®rst non-coding exon. The binding of BCL6 protein to the region represses transcription from its own promoter. This may be the mechanism that promptly attenuates BCL6 transcription after it has been induced under certain conditions, but the signi®cance of this autoregulation is not clear at this time.
In conclusion, the ®rst exon and intron regions of the BCL6 gene which are aected frequently in B-cell lymphomas contain negative regulatory elements. The ES and IS regions identi®ed in this study may mediate some signals that downregulate BCL6 transcription, and the disruption of this control mechanism may play a role in lymphomagenesis. It is therefore important to identify such signals, in addition to that of CD40-CD40L, as well as to isolate and characterize the ISbinding proteins. 
